Necitumumab in Metastatic Squamous Cell Lung Cancer-Reference-Cited by-同舟云学术

Necitumumab in Metastatic Squamous Cell Lung Cancer

Published:2015-12-01 Issue:9 Volume:1 Page:1293
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Goldstein Daniel A.¹,Chen Qiushi²,Ayer Turgay²,Howard David H.³,Lipscomb Joseph³,Ramalingam Suresh S.¹,Khuri Fadlo R.¹,Flowers Christopher R.¹

Affiliation:

1. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia

2. H. Milton Stewart School of Industrial & Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia

3. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia3Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer;BMC Cancer;2024-02-21

2. Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer;PLOS ONE;2023-08-24

3. Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States;Breast Cancer: Targets and Therapy;2022-12

4. Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA;Advances in Therapy;2022-08-09

5. Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer;Advances in Therapy;2021-05-21